Vancouver, British Columbia, April 20, 2026 – TheNewswire – Noveris Health Sciences Inc. (the “ Company ”) (CSE: NVRS) (FSE: 0NF0) (OTC: MYCOF) announces that, as a result of a review by the British Columbia Securities Commission (the “ BCSC ”), the Company is issuing the following press release to clarify recent disclosure included in the Company's LIFE offering document dated March 11, 2026 (the “ LIFE Offering Document ”, and the offering to which it relates, the “ LIFE Offering ”) and news releases dated March 13 and 18, 2026. Following the BCSC review, the Company did not qualify for the LIFE Offering and, as a result, the Company will be relying on alternate exemptions and filing an amended Report of Exempt Distribution. The securities issued under the LIFE Offering are in the process of being cancelled and re-issued with four-month restrictive holds.